Brief report: a double-blind study of naltrexone in infantile autism.
INSERM U 155--Unité de Recherche en Génétique Epidémologique, Paris.
M
M
Leboyer
M P
MP
Bouvard
J M
JM
Launay
F
F
Tabuteau
D
D
Waller
M
M
Dugas
B
B
Kerdelhue
P
P
Lensing
J
J
Panksepp
D000293:Adolescent; D001127:Arginine Vasopressin / Q000097:blood; D001321:Autistic Disorder / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D002648:Child; D002675:Child, Preschool; D004298:Dopamine / Q000097:blood; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004837:Epinephrine / Q000097:blood; D005260:Female; D006801:Humans; D008297:Male; D009271:Naltrexone / Q000627:therapeutic use*; D009638:Norepinephrine / Q000097:blood; D001615:beta-Endorphin / Q000097:blood
D001127:Arginine Vasopressin; D009271:Naltrexone; D001615:beta-Endorphin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine